INTU and breast carcinoma: Taken together, our study demonstrates that CLPs of luminal A breast cancer cells can be induced to differentiate to a more benign phenotype in conjunction with their microenvironment by promoting downstream signaling that emanates from Int-αvβ3, such as inhibition of Notch4 signaling.